Table 7.
Budget impact analysis
| Uncoated catheters (UC) |
Hydrophilic coated catheters (HC) |
Total budget impact | Incremental cost in comparison to current scenario | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | UC market share | UC users cohort | UC patients' monitoring | UC UTIs | UC haematuria | UC catheters | UC total cost | HC market share | HC users cohort | HC patients’ monitoring | HC UTIs | HC haematuria | HC catheters | HC total cost | ||
| Current scenario | ||||||||||||||||
| 0 | 20% | 7800 | €7 406 202 | €17 553 353 | €238 749 | €2 814 182 | €28 012 486 | 80% | 31 200 | €29 685 875 | €33 066 569 | €1 291 904 | €76 991 688 | €141 036 036 | €169 048 522 | |
| 1 | 20% | 57 | €7 382 273 | €17 496 692 | €237 978 | €2 805 089 | €27 922 032 | 80% | 228 | €29 711 701 | €33 095 438 | €1 293 028 | €77 058 664 | €141 158 831 | €169 080 863 | |
| 2 | 20% | 57 | €7 356 951 | €17 436 723 | €237 162 | €2 795 467 | €27 826 302 | 80% | 228 | €29 730 740 | €33 116 734 | €1 293 856 | €77 108 040 | €141 249 370 | €169 075 672 | |
| 3 | 20% | 57 | €7 330 174 | €17 373 319 | €236 298 | €2 785 292 | €27 725 083 | 80% | 228 | €29 742 674 | €33 130 139 | €1 294 376 | €77 138 987 | €141 306 176 | €169 031 259 | |
| 4 | 20% | 57 | €7 301 592 | €17 305 645 | €235 377 | €2 774 431 | €27 617 045 | 80% | 228 | €29 746 001 | €33 133 978 | €1 294 520 | €77 147 612 | €141 322 112 | €168 939 157 | |
| 5 | 20% | 57 | €7 270 867 | €17 232 905 | €234 387 | €2 762 756 | €27 500 915 | 80% | 228 | €29 739 259 | €33 126 624 | €1 294 227 | €77 130 119 | €141 290 230 | €168 791 145 | |
| New scenario | ||||||||||||||||
| 0 | 20% | 7800 | €7 406 202 | €17 553 353 | €238 749 | €2 814 182 | €28 012 486 | 80% | 31 200 | €29 685 875 | €33 066 569 | €1 291 904 | €76 991 688 | €141 036 036 | €169 048 522 | €0 |
| 1 | 17% | 48 | €6 274 932 | €14 872 189 | €202 281 | €2 384 326 | €23 733 728 | 83% | 237 | €30 825 890 | €34 336 517 | €1 341 516 | €79 948 364 | €146 452 287 | €170 186 014 | €1 105 151 |
| 2 | 17% | 48 | €6 253 408 | €14 821 214 | €201 587 | €2 376 147 | €23 652 356 | 83% | 237 | €30 845 643 | €34 358 612 | €1 342 376 | €79 999 592 | €146 546 222 | €170 198 578 | €1 122 906 |
| 3 | 12% | 34 | €4 398 104 | €10 423 991 | €141 779 | €1 671 175 | €16 635 050 | 88% | 251 | €32 716 942 | €36 443 153 | €1 423 813 | €84 852 886 | €155 436 794 | €172 071 844 | €3 040 584 |
| 4 | 12% | 34 | €4 380 955 | €10 383 387 | €141 226 | €1 664 659 | €16 570 227 | 88% | 251 | €32 720 602 | €36 447 376 | €1 423 972 | €84 862 373 | €155 454 323 | €172 024 550 | €3 085 393 |
| 5 | 11% | 31 | €3 998 977 | €9 478 098 | €128 913 | €1 519 516 | €15 125 503 | 89% | 254 | €33 084 926 | €36 853 369 | €1 439 828 | €85 807 258 | €157 185 381 | €172 310 884 | €3 519 739 |
| Total incremental cost | €11 873 774 | |||||||||||||||
HC, hydrophilic coated catheters; UC, uncoated catheters; UTIs, urinary tract infections.